According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -111,27ย โฌ. In 2021 the company made an earnings per share (EPS) of -7,78ย โฌ an increase over its 2020 EPS that were of -10,28ย โฌ.